Jefferies lowered the firm’s price target on Sabra Health Care to $20 from $21 and keeps a Buy rating on the shares as part ...

Jefferies lowered the firm’s price target on Healthpeak Properties to $23 from $26 and keeps a Buy rating on the shares as ...

JPMorgan Chase & Co. lifted its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 222.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 9,886,917 ...

On Tuesday, Sabra Health Care REIT Inc (SBRA) stock saw a modest uptick, ending the day at $17.32 which represents a slight increase of $0.28 or 1.64% from the prior close of $17.04. The stock opened ...

Sabra Health Care REIT's balance sheet strengthened, with Moody's upgrading its outlook to positive. Read why SBRA stock is a ...

Sabra (SBRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SBRA.

In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on Sabra Healthcare REIT (SBRA – Research Report), with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...

In any case, new support levels are usually revised to the database at the beginning of the next trading session. Short SBRA slightly under 17.44, target n/a, stop loss @ 17.49 Details The technical ...